SAB Biotherapeutics Inc.
SABS | NASDAQ
$3.49
+$0.10 (+2.95%)
Sep 22, 2026, 12:20 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 114.7K | n/a | 263.14K | 944.58K | 305.01K | 1.27M | 85.52K | 581.1K | 2.16M | 3.59M | 6.35M | 11.8M | 11.06M | 14.68M | 18.21M | 16.93M |
Cost of Revenue | n/a | 752.67K | 763.3K | 765.47K | 822K | 7.66M | 785.71K | 966.86K | 1.02M | 1.98M | 944.4K | 985.45K | 892.27K | 923.17K | 923.52K | 909.91K | 8.58M | 13.32M | 10.65M | 410.63K | 18.68M | 12.78M |
Gross Profit | n/a | -752.67K | -763.3K | -765.47K | -822K | -7.66M | -671.02K | -966.86K | -758.86K | -1.04M | -639K | 281.92K | -806.75K | -342.07K | 1.24M | 2.68M | -2.23M | -1.52M | 410.34K | 14.27M | -473.9K | 4.15M |
Operating Income | -23.38M | -20M | -15.77M | -12.68M | -9.73M | -10.77M | -10.01M | -11.31M | -10.2M | -11.39M | -18.87M | -5.32M | -6.48M | -7.4M | -7.86M | -7.81M | -6.54M | -6.71M | -7.34M | -3.99M | -2.87M | 813.92K |
Interest Income | 1.71M | 1.05M | 700.74K | 655.23K | 13.56K | 62.5K | 136.37K | 277.17K | 374.56K | 497.89K | 484.05K | 14.36K | 28.57K | 57.99K | 29.93K | 17.39K | 15.82K | 7.93K | 14.87K | 3.77K | 5.3K | 5.51K |
Pretax Income | -22.49M | -18.87M | -16.86M | 45.45M | -10.11M | -5.2M | -11.39M | -10.35M | -7.34M | -5.03M | -22.86M | -5.1M | -6.88M | -7.35M | -7.85M | -7.08M | -4.87M | 1.08M | -11.55M | -4.06M | -2.94M | 1.41M |
Net Income | -22.49M | -18.87M | -16.86M | 45.45M | -10.11M | -5.2M | -11.39M | -10.35M | -7.34M | -5.03M | -22.86M | -5.1M | -6.88M | -7.35M | -7.87M | -7.08M | -4.78M | 985.86K | -11.55M | -4.06M | -2.94M | 1.41M |
Selling & General & Admin | 7.21M | 5.87M | 5.04M | 3.71M | 2.74M | 3.11M | 1.71M | 2.51M | 2.64M | 2.23M | 14.88M | 2.57M | 2.03M | 2.55M | 1.96M | 3.16M | 4.31M | 5.19M | 7.75M | 3.23M | 2.4M | 3.33M |
Research & Development | 16.17M | 13.38M | 10.73M | 8.95M | 7M | 7.66M | 7.63M | 7.83M | 6.8M | 8.12M | 4.3M | 4.02M | 3.64M | 4.51M | 7.14M | 7.33M | 8.58M | 13.32M | 10.65M | 15.03M | 18.68M | 12.78M |
Other Expenses | n/a | n/a | -763.3K | -743.76K | -822K | -7.66M | n/a | n/a | n/a | n/a | -943.62K | -986.16K | n/a | n/a | n/a | n/a | -8.58M | -13.32M | -10.65M | n/a | -18.68M | -12.78M |
Operating Expenses | 23.38M | 19.25M | 15.01M | 11.91M | 8.91M | 3.11M | 9.34M | 10.34M | 9.44M | 10.35M | 18.23M | 5.6M | 5.67M | 7.06M | 9.1M | 10.49M | 4.31M | 5.19M | 7.75M | 18.26M | 2.4M | 3.33M |
Interest Expense | 62K | 62.74K | 63.46K | 43.29K | 64.35K | 69.57K | 70.88K | 78.04K | 93.12K | 76.37K | 77.88K | 69.7K | 75.32K | 92.39K | 87.7K | 70.63K | 71.24K | 72.02K | 294.46K | 78.56K | 74.43K | 75.19K |
Selling & Marketing Expenses | n/a | -730.97K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 23.38M | 20M | 15.77M | 12.68M | 9.73M | 10.77M | 10.12M | 11.31M | 10.46M | 12.34M | 19.18M | 6.59M | 6.56M | 7.98M | 10.02M | 11.4M | 12.89M | 18.51M | 18.4M | 18.67M | 21.08M | 16.11M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 25.63K | n/a | -92.28K | 92.28K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 79.75M | 53.56M | 47.61M | 10.66M | 9.29M | 9.29M | 9.26M | 9.26M | 9.26M | 9.24M | 5.93M | 5.24M | 5.04M | 5.04M | 5.04M | 4.3M | 4.3M | 4.31M | 4.35M | 4.35M | 4.35M | 4.35M |
Shares Outstanding (Diluted) | 79.75M | 53.56M | 47.61M | 77.86M | 9.29M | 9.29M | 9.26M | 9.26M | 9.26M | 9.24M | 5.93M | 5.24M | 5.04M | 5.04M | 5.04M | 4.3M | 4.3M | 4.58M | 4.35M | 4.35M | 4.35M | 4.35M |
EPS (Basic) | -0.28 | -0.35 | -0.06 | 4.26 | -1.09 | -0.56 | -1.23 | -1.12 | -0.79 | -0.54 | -3.86 | -0.97 | -1.36 | -1.46 | -1.56 | -1.60 | -1.11 | 0.23 | -4.11 | -0.07 | -0.68 | 0.32 |
EPS (Diluted) | -0.28 | -0.35 | -0.81 | 0.58 | -1.09 | -0.56 | -1.23 | -1.12 | -0.79 | -0.54 | -3.86 | -0.97 | -1.36 | -1.46 | -1.56 | -1.60 | -1.11 | 0.22 | -4.11 | -0.07 | -0.68 | 0.32 |
EBITDA | -21.63M | -18.05M | -16.03M | 46.25M | -9.23M | -4.35M | -10.54M | -9.3M | -6.22M | -2.96M | -21.83M | -4.05M | -5.91M | -6.34M | -6.84M | -6.1M | -4.05M | 1.83M | -10.64M | -3.57M | -2.61M | 1.76M |
EBIT | -22.43M | -18.81M | -16.8M | 45.49M | -10.05M | -5.13M | -11.32M | -10.27M | -7.24M | -4.95M | -22.78M | -5.03M | -6.81M | -7.26M | -7.76M | -7.01M | -4.8M | 1.15M | -11.26M | -3.98M | -2.87M | 1.49M |
Depreciation & Amortization | 800K | 752.67K | 763.3K | 765.47K | 822K | 778.3K | 785.71K | 966.86K | 1.02M | 1.98M | 944.4K | 985.45K | 892.27K | 923.17K | 923.52K | 909.91K | 749.19K | 677.44K | 619.98K | 410.63K | 258.89K | 277.22K |
Add to Watchlist
Select watchlists to add or remove SABS